Cancer Research

Study Identifies p53 Mutants Sensitive to APR-246 in Ovarian Cancer
Research & Development Study Identifies p53 Mutants Sensitive to APR-246 in Ovarian Cancer

Ovarian cancer continues to represent a formidable obstacle in gynecologic oncology, largely because the disease is frequently detected at advanced stages and tends to develop rapid resistance to standard therapeutic interventions. At the core of this malignancy’s formidable resilience is the TP53

Oral AML Combination Therapy – Review
Research & Development Oral AML Combination Therapy – Review

The landscape of acute myeloid leukemia treatment is undergoing a radical transformation as the industry pivots from hospital-bound infusions toward the convenience of at-home oral regimens. This transition is not merely a change in delivery but a fundamental shift in how oncologists manage

DNA-Guided CRISPR Systems – Review
Research & Development DNA-Guided CRISPR Systems – Review

The long-held biological dogma that gene-editing machinery must rely on fragile RNA strands to find its target has finally been dismantled by a pioneering shift toward DNA-guided navigation. For years, the scientific community accepted the inherent instability of RNA as a necessary trade-off for

Can Predictive Modeling Detect Early Mobility Decline?
Tech & Innovation Can Predictive Modeling Detect Early Mobility Decline?

The global demographic shift toward an aging population presents a massive challenge for healthcare systems tasked with maintaining functional independence for millions of people. Proactive screening for Early Mobility Limitations (EMLs) has emerged as a critical best practice to prevent the sudden

Can CAR-T Cell Therapy Effectively Reset the Immune System?
Research & Development Can CAR-T Cell Therapy Effectively Reset the Immune System?

Modern medical science is increasingly looking toward the most aggressive cancer treatments as a potential solution for the chronic, debilitating nature of systemic autoimmune diseases. A pioneering clinical breakthrough at the University Hospital Erlangen in Germany has demonstrated that Chimeric

Can New Molecular Targets Finally Reverse Liver Fibrosis?
Research & Development Can New Molecular Targets Finally Reverse Liver Fibrosis?

The human liver possesses an extraordinary capacity to heal, yet when chronic injury triggers the relentless buildup of scar tissue, the organ often crosses a threshold where natural recovery feels like a distant impossibility. This biological hardening, known as fibrosis, silently accumulates

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later